Award
Delivery Order #SPE2D326F214C
Pfizer Delivery Order for Injectable Tranexamic Acid
Buyer
Defense Logistics Agency
Award Amount
$179.68
Ceiling
$179.68
Awarded
June 24, 2026
Period of Performance
Jun 24, 2026 – Jun 25, 2026
Identifier
SPE2D326F214C
NAICS
325412
This is a short-term delivery order under Pfizer Inc.’s existing Department of Defense indefinite-delivery contract. Pfizer, a pharmaceutical manufacturer and distributor, is supplying Cyklokapron (tranexamic acid) injection, a medication used to help control bleeding. The order covers the specified injectable product for delivery in New York and supports the Defense Logistics Agency’s procurement of medicines for military health needs. It is issued under a parent contract described as competitively awarded; the record does not state the competition method for this individual order. The parent contract is a long-term pharmaceutical supply vehicle. The order was recently awarded, with performance scheduled over a brief period. No acquisition program, subcontractor, prior related order, or original solicitation details are provided.
Description
4572220577!CYKLOKAPRON 1,000 MG/10 ML VL 10ML